Hexazide

Quick links to important sections

Hexazide

Method of action: Diuretic

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hexazide

Property Description
Active ingredient Hydrochlorothiazide (HCTZ)
Form Oral tablet
Pharmacological class Thiazide diuretic
General purpose Management of high blood pressure and fluid retention
Origin Synthetic compound

The Identity and Classification of Hexazide: A Thiazide Diuretic

Hexazide is a recognized medicinal product containing the active substance Hydrochlorothiazide (HCTZ), which is pharmacologically classified as a thiazide-type diuretic. This drug belongs to a class of agents clinically recognized for their established role in managing cardiovascular volume imbalances.

Hydrochlorothiazide itself is a synthetic compound that is supplied as a solid oral tablet intended for oral administration and requires a prescription. The medication's classification as a thiazide makes it a widely studied compound in clinical pharmacology, often serving as a reference standard among diuretics. Pharmacological studies confirm that HCTZ remains a commonly prescribed agent, used either as a standalone agent (monotherapy) or as a critical component in various fixed-dose combinations to optimize blood pressure control.

Composition, Action Principle, and General Purpose

The core of Hexazide's composition is its active ingredient, Hydrochlorothiazide. Its fundamental action principle is the promotion of salt and water excretion, a process where it works by inhibiting the reabsorption of sodium and chloride ions in the kidney. This physiological action results in the primary therapeutic benefit of reducing the overall volume of fluid circulating in the bloodstream.

This general purpose makes Hydrochlorothiazide an effective agent for managing conditions characterized by excess fluid, such as edema (fluid retention), and for contributing to the long-term control of systemic hypertension. For instance, it is a routine choice for managing a patient's high blood pressure (a typical use scenario), thereby reducing stress on the heart and blood vessels.

Regulatory References

  1. NIH StatPearls: Hydrochlorothiazide
  2. MedlinePlus Drug Information on Hydrochlorothiazide

What side effects are possible with Hexazide?

Possible side effects and safety information

Hexazide (Hydrochlorothiazide) has an official safety profile categorized by the frequency and physiological system affected, as established in regulatory documents from health authorities like the FDA and EMA.

Adverse Reaction Scope

The most frequent safety characteristics relate to Metabolism and Nutrition Disorders, primarily involving Hypokalemia (low potassium), which is formally classified as a Very Common side effect. Other Common reactions include dizziness, orthostatic hypotension (low blood pressure upon standing), nausea, vomiting, and other electrolyte imbalances.

Classification Examples of Documented Effects
Common Dizziness, Hyperuricemia, Orthostatic Hypotension
Rare/Very Rare Pancreatitis, Agranulocytosis, Severe Skin Reactions

Serious Adverse Reactions

Official labels document specific rare but serious adverse reactions. These include Acute Angle-Closure Glaucoma and Acute Myopia, which are ocular emergencies that typically appear shortly after treatment initiation. Severe Blood Dyscrasias (e.g., aplastic anemia) and serious Skin Reactions (e.g., Stevens-Johnson Syndrome) are classified as very rare events. Furthermore, an increased risk of certain Non-Melanoma Skin Cancers is associated with long-term, cumulative use.

Safety Considerations and Constraints

The medicine is subject to specific constraints regarding patient conditions. It is contraindicated in patients with Anuria or severe renal impairment (creatinine clearance < 30 mL/min). Caution is advised in individuals with hepatic impairment, as fluid and electrolyte changes may precipitate hepatic coma. Use during pregnancy and lactation carries documented risks to the fetus and neonate, as the drug crosses the placenta and is excreted in breast milk.

Overdose and Emergency Response

The officially documented profile for Hexazide (Hydrochlorothiazide) overdose is based on the exaggerated loss of fluid and essential electrolytes, an event that requires immediate medical intervention.

Overdose Manifestations Severe Outcomes and Emergency Actions
Documented Signs: Overdose is primarily defined by signs of severe fluid and electrolyte depletion, including low blood pressure (hypotension), a fast heartbeat (tachycardia), dry mouth, thirst, confusion, and generalized weakness. Laboratory findings commonly include hypokalemia and hyponatremia. Life-Threatening Risks: Severe, documented outcomes resulting from critical depletion are seizures, coma, and serious cardiac rhythm disturbances, particularly ventricular arrhythmias. The risk for severe effects is noted to be increased in patients with existing renal impairment.

When to Seek Immediate Medical Help:

Regulatory guidance mandates that immediate medical attention or emergency medical treatment must be sought upon suspicion of Hexazide overdose or if any severe symptoms are observed. This action is critical if an individual has collapsed, experienced a seizure, or cannot be easily awakened. Management is defined as symptomatic and supportive treatment, focusing on correcting the fluid and electrolyte deficits. Treatment procedures documented in regulatory materials may include the administration of intravenous fluids, activated charcoal, and continuous monitoring of vital signs and cardiac function (ECG). No specific pharmacological antidote is known for this overdose scenario.

Therapeutic Uses of Hexazide

What Hexazide Treats: Main Uses and Benefits

Hexazide (Hydrochlorothiazide) is commonly used to provide supportive therapeutic benefit by managing various chronic physiological imbalances, focusing on easing the symptom load and generally contributing to lowering health risks. This medication is commonly used to help with symptoms related to systemic imbalance in clinical contexts. Its uses are centered on managing blood pressure and fluid disorders.


Management of Chronic High Blood Pressure

This therapeutic domain is applied in conditions marked by increased physiological stress from high arterial pressure. The primary therapeutic benefit is controlling blood pressure, which may generally contribute to lowering the risk of major complications. This process supports long-term stability and assists with maintaining functional well-being during periods of heightened systemic burden.


Symptom Management for Fluid Retention (Edema)

Hexazide is relevant in clinical settings marked by conditions involving episodic or fluctuating manifestations of fluid overload, often leading to generalized swelling. It helps address symptom clusters associated with underlying conditions like congestive heart failure or liver and kidney diseases. This application contributes to improved comfort by helping to ease the overall symptom burden associated with fluid retention.


Supportive Use for Specific Renal Issues

The medication is also applied when appropriate in situations involving symptoms linked to organ-specific functional stress. It may assist with preventing the recurrence of certain calcium kidney stones (nephrolithiasis) in individuals with specific metabolic profiles. This supportive use contributes to easing the overall symptom load associated with these chronic conditions.


Quick Fact: Relief for Swelling and High Blood Pressure

This medication is generally considered relevant for conditions that produce chronic fluid retention and is used as a foundational therapy for long-term blood pressure control.

Regulatory References

  1. NIH MedlinePlus Drug Information on Hydrochlorothiazide

Eligibility and Restrictions for Use

Eligibility and Contraindications for Hexazide

The eligibility for Hexazide (Hydrochlorothiazide) is strictly defined by regulatory authorities and includes both absolute prohibitions and required cautions based on a patient's health status and life stage. The drug is contraindicated and must not be used by patients with anuria (absence of urine output) or a known hypersensitivity to Hydrochlorothiazide or any sulfonamide-derived drugs.

Contraindications also apply to severe internal conditions, including severe renal impairment and severe hepatic impairment (liver failure), due to the risk of ineffective treatment or precipitating serious complications like hepatic coma. Additionally, use is prohibited in the second and third trimesters of pregnancy and is generally not recommended during the first trimester or while breastfeeding.

Age-Group and Condition Restrictions

Population Group Regulatory Status
Pediatric Patients Approved for use in children six months of age and older.
Older Adults (ge 65 years) Use is permitted, but requires caution due to potential age-related decline in kidney or liver function.

Use requires special caution and monitoring in patients with pre-existing conditions such as Systemic Lupus Erythematosus (SLE), diabetes mellitus (due to effects on glucose tolerance), and a history of gout or hyperuricemia.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Hexazide (Hydrochlorothiazide) has officially documented interaction patterns that are primarily classified as pharmacokinetic (exposure-altering) or pharmacodynamic (additive effects) in regulatory documentation.

Formally Contraindicated Combinations

Co-administration with Lithium is contraindicated. Hydrochlorothiazide reduces the renal clearance of Lithium, which can lead to a significant increase in serum Lithium concentrations and elevate the risk of toxicity.


Clinically Significant Interactions

Interacting Substance/Class Officially Documented Interaction Type Official Effect/Restriction
Cholestyramine & Colestipol Resins Pharmacokinetic (Reduced Absorption) HCTZ must be taken at least 4 hours before or 4 to 6 hours after the resin to mitigate significantly reduced absorption.
Corticosteroids, ACTH, Amphotericin B Pharmacodynamic (Additive Effect) Increased potential for potassium depletion (hypokalemia).
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Pharmacodynamic (Additive Effect) May reduce the diuretic and antihypertensive effects of HCTZ, with an increased risk for those with impaired renal function.
Alcohol, Barbiturates, Narcotics Pharmacodynamic (Additive Effect) Documented risk of exacerbating orthostatic hypotension.

Population-Dependent Interaction Notes

The risk of interaction severity, particularly those concerning renal clearance or function (e.g., with Lithium or NSAIDs), is explicitly noted as increased in patients with impaired renal function.

Mechanism of Action

Modulation of Renal Fluid and Electrolyte Homeostasis

Hexazide primarily engages mechanisms that inhibit the Sodium-Chloride Symporter (NCC) in the distal renal tubules . This targeted pathway adjustment reduces the kidney's reabsorption of sodium and water. This initiates a molecular cascade that results in the physiological consequence of reduced plasma volume and extracellular fluid. This specific mechanism affects systems that regulate total fluid volume and electrolyte concentrations.


Regulation of Cellular Excitation and Mediator Release

Additionally, the drug works by modulating specific voltage-gated potassium (Kv) channels in non-renal cells, thereby altering the cell's membrane potential and its capacity to release signaling mediators. This activity influences feedback regulation within local pathways, which modifies the activity state of targeted metabolic or vascular processes and influences the resultant signaling cascade following mediator release.

Dosage and Administration Information

Hexazide (Hydrochlorothiazide) is administered via the oral route, primarily using approved dosage forms such as tablets (e.g., 12.5 mg, 25 mg, 50 mg) and capsules. The medication can be taken with or without food; however, its absorption is known to be reduced when co-administered with certain binding resins.

The standard usage pattern involves administration once daily, with regulatory labeling generally advising that the dose be taken in the morning. This timing protocol is established to mitigate the potential for nocturia, which could interrupt sleep. Dosing is specified by the condition being managed. For the long-term control of hypertension, the typical starting dose is 25 mg once daily, with the maximum daily dose generally limited to 50 mg. For the management of fluid retention (edema), the required daily dose may range from 25 mg up to 100 mg, and treatment may be structured as intermittent therapy (e.g., on alternate days).

Official instructions define limits on use for specific populations. The medicine is not recommended for patients with severe renal impairment (creatinine clearance < 30 mL/min) due to a loss of efficacy in this setting. Furthermore, pediatric dosing is weight-based, adhering to specific maximum daily amounts. If a dose is missed, the recommended procedure is to take the dose as soon as remembered, unless it is near the time for the subsequent dose, in which case the standard schedule should be resumed without doubling the amount.

Recent Clinical Evidence

Evidence for use in Managing Chronic High Blood Pressure

Research was studied for Hexazide, primarily through large-scale Randomized Controlled Trials (RCTs) and Systematic Reviews in Adults with essential high blood pressure. These trials were evaluated in populations that included older adults and those with comorbid cardiovascular risk factors. Outcomes were studied for monitoring physiological strain, specifically looking at changes in Blood Pressure (BP) measurements and the occurrence of Major Cardiovascular Events (like stroke and heart attack).

The research describes patterns related to changes in BP across the groups studied. However, synthesis of evidence highlights differences in the magnitude of BP change compared to some other diuretic agents. The evidence was observed in some studies to provide mixed findings regarding the prevention of cardiovascular events, particularly when compared to certain alternatives. The certainty remains low regarding the comparative long-term effects of Hexazide in this context.

Evidence for use in Managing Fluid Retention (Edema)

The core evidence describing the properties of Hexazide for fluid retention research includes Pharmacological and Pharmacodynamic Studies. These were evaluated in populations experiencing fluid overload associated with conditions such as Congestive Heart Failure and Hepatic Cirrhosis. Studies monitored outcomes related to functional imbalance, tracking changes in body weight and outcomes related to physical discomfort (swelling).

Research suggests that the physiological response may be reduced in individuals with more severe degrees of renal impairment. The evidence is limited regarding its primary role as a standalone agent for severe fluid retention, where comparative evidence is lacking against stronger diuretic medications.

Research Summary and Uncertainty

Research was also studied for supportive use in individuals with recurrent calcium kidney stones linked to high urine calcium levels, primarily through observational studies that track recurrence rates. Overall, comparative evidence is lacking for some long-term outcomes, and data for certain groups, such as those with advanced kidney dysfunction, remain insufficient to fully characterize the compound’s utility.

Frequently Asked Questions (FAQ)

Common questions about Hexazide (FAQ)

Q: Is Hexazide the same as [Name of a similar common drug]? What is the key difference?

A: Hexazide belongs to a class of medications known as thiazide-type diuretics and is frequently used as a reference standard within this group. Studies and official information indicate that the effect on blood pressure may have differences in magnitude when Hexazide is compared to some other diuretic agents.

Q: Does taking Hexazide require me to change my diet?

A: According to official product information, the medication can be taken with or without food. However, the potential for low potassium (Hypokalemia) is noted as a very common side effect. The potential for low potassium is noted, which relates to electrolyte balance and may involve dietary considerations.

Q: Are there any common side effects of Hexazide that usually fade over time?

A: Official safety information classifies the frequency of common effects such as dizziness and orthostatic hypotension (low blood pressure upon standing). However, regulatory documents do not specifically state whether these common effects are expected to fade or diminish over a specific time period.

Q: Can Hexazide affect my sleep schedule or energy levels?

A: Regulatory labeling advises taking the dose in the morning to prevent nocturia (frequent nighttime urination), which could interrupt sleep. Official documents describe common side effects such as dizziness and orthostatic hypotension, which are effects that could potentially impact general alertness or function.

Q: What does the term 'contraindication' mean in relation to Hexazide?

A: In official documents, a 'contraindication' is a strict rule that refers to a situation where the medication is specified not to be used, such as with severe kidney impairment. This is because the condition or drug combination could lead to severe risk or a loss of efficacy.

Q: How long is a typical course of treatment with Hexazide?

A: The duration of treatment varies based on the condition being managed, according to official information. It is noted for use in the long-term control of high blood pressure. For managing fluid retention (edema), treatment may sometimes be structured as intermittent therapy, such as on alternate days.

Q: Is there a maximum time someone is advised to take Hexazide, according to official documents?

A: Regulatory documents do not formally define a maximum duration of use. However, official safety notes associate an increased risk of certain types of Non-Melanoma Skin Cancers with the long-term, cumulative use of the drug.

Q: What are the general expectations about the benefit of taking Hexazide?

A: The general purpose of Hexazide is to promote the excretion of salt and water. This physiological action is intended to reduce the overall volume of fluid in the bloodstream, which is the underlying purpose for managing fluid retention (edema) and contributing to the control of high blood pressure.

Q: Is Hexazide safe to take while operating a vehicle or heavy machinery?

A: Official safety information lists dizziness and orthostatic hypotension (low blood pressure upon standing) as common side effects of this medication. Due to these common effects, caution is generally noted regarding activities that require full alertness, such as driving or operating heavy machinery.

Q: What is the difference between the brand name and generic versions of Hexazide?

A: Hexazide is the brand name product that contains the active substance Hydrochlorothiazide (HCTZ), which is the drug's generic name. The generic HCTZ substance is the core medicine and is commonly supplied as an oral tablet.

Q: Can Hexazide affect the results of certain lab tests or blood work?

A: Yes, the medication may cause changes that are detectable through laboratory tests. According to regulatory documents, frequently documented effects include changes in metabolic markers, such as Hypokalemia (low potassium) and Hyperuricemia (high uric acid).

Q: What does the term 'drug-drug interaction' mean for Hexazide?

A: Official product information classifies drug-drug interactions as patterns where one drug affects the other. These interactions are noted as either pharmacokinetic (changing how much of the drug is absorbed) or pharmacodynamic (causing additive effects, like increasing the risk of low blood pressure).

Q: Are allergic reactions to Hexazide common?

A: Hexazide is a medication that is specified not to be used (contraindicated) if a patient has a known hypersensitivity to the drug or related sulfonamide-derived drugs. Serious allergic-type reactions, such as severe skin conditions, are officially classified as very rare events.

Q: What types of food or drinks are noted to interact with Hexazide?

A: Official warnings note that alcohol has a pharmacodynamic interaction that documents a risk of exacerbating orthostatic hypotension (dizziness upon standing). The medication must also be taken separately from certain binding resins to prevent significantly reduced absorption.

Q: Why do official documents emphasize blood monitoring while on Hexazide?

A: Monitoring is emphasized due to the drug’s effects on the body’s metabolism and nutrition. Regulatory documents classify the most frequent side effect as Hypokalemia, which is low potassium. This and other electrolyte changes necessitate close blood monitoring.

Q: How does Hexazide's safety classification compare to other drugs in its category?

A: Hexazide (Hydrochlorothiazide) is a widely studied thiazide-type diuretic often used as a standard reference agent in its class. Regulatory evidence describes that changes in blood pressure may differ in magnitude when compared to some other diuretic agents.

Q: Is it normal to feel [Vague symptom, e.g., 'a bit strange'] after starting Hexazide?

A: Official information notes that several common side effects may occur when starting treatment. These include specific symptoms such as dizziness, orthostatic hypotension, nausea, and vomiting.

Q: What are the official sources for patient information about Hexazide?

A: The foundational patient information for Hexazide is derived from regulatory and governmental health authorities. These sources include documents from the FDA (U.S.), NIH/DailyMed, EMA (Europe), and other national health authority documents.

Q: Is it possible to take Hexazide if I have a history of [Specific common chronic condition, e.g., mild heart problems]?

A: Use requires special caution and monitoring in patients with certain pre-existing chronic conditions. These include a history of Systemic Lupus Erythematosus (SLE), diabetes mellitus, and a history of gout or hyperuricemia.

Q: How does the effectiveness of Hexazide change with age?

A: Official labeling notes that use in older adults (aged 65 years and over) requires caution due to potential age-related decline in kidney or liver function. Research also suggests the physiological response may be reduced in individuals with more severe kidney impairment.

How should Hexazide be stored and disposed of?

The official regulatory requirements for storing and disposing of Hexazide (Hydrochlorothiazide tablets) strictly define specific handling and environmental conditions.

Storage Conditions

Requirement Classification
Temperature Controlled Room Temperature (20 C to 25 C)
Protection Keep protected from light and moisture
Container Store in the original container, tightly closed
Child Safety Keep out of the sight and reach of children

Disposal Instructions

Official disposal procedures mandate that unused or expired medicine must be discarded safely by following local regulations. The preferred method is to utilize authorized drug take-back programs or collection points. If a take-back option is unavailable, the product should be mixed with an undesirable substance, placed in a sealed container, and then thrown in the household trash. The tablets should not be flushed down a toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hexazide found in:

A-Z Index: